![Dror Bashan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dror Bashan
Chief Executive Officer at
PROTALIX BIOTHERAPEUTICS, INC.
Net worth: 5 M $ as of 2026-05-30
Profile
Dror Bashan is currently President, Chief Executive Officer & Director at Protalix Biotherapeutics, Inc. since 2019.
Formerly, Mr. Bashan was Senior VP-Global Business Development at Teva Pharmaceutical Industries Ltd. Education includes undergraduate and MBA degrees from Tel-Aviv University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-29 | 2,532,934 ( 3.14% ) | 5 M $ | 2026-05-30 |
Dror Bashan active positions
| Companies | Position | Start |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Chief Executive Officer | 2019-06-29 |
Former positions of Dror Bashan
| Companies | Position | End |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - |
Training of Dror Bashan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
 Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
- Stock Market
- Insiders
- Dror Bashan
